EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
155 hedge funds and large institutions have $508M invested in Eagle Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 64 increasing their positions, 54 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
155
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$9.25M | |
| 2 | +$5.36M | |
| 3 | +$4.72M | |
| 4 |
D.E. Shaw & Co
New York
|
+$2.05M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.73M |
Top Sellers
| 1 | -$14.3M | |
| 2 | -$7.18M | |
| 3 | -$6.07M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$4.31M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$3.63M |